2m 2m 2m 2m 2m 2m 2m
Rein Therap (RNTX)
NASDAQ
$0.65+$0.05 (+7.90%)
Price as of Oct 23, 2026 4:08 AM EDT- $53.9MMarket Cap
- -52.19%1-Year Change
- BiotechnologyIndustry
Rein Therap (RNTX)
$0.65+$0.05 (+7.90%)
RNTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.60 | ||
Change | -$0.02 (-3.59%) | ||
Open | $0.62 | ||
High | $0.62 | ||
Low | $0.59 | ||
Previous Close | $0.62 | ||
Volume | 305,247 | ||
30-Day Average Volume | 424,414 | ||
1-Week Change | -4.08% | ||
1-Month Change | -24.20% | ||
1-Year Change | -52.19% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 86.3M | ||
Total Assets | $66.0M | ||
Market Cap | $53.9M | ||
Enterprise Value | $45.4M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$6.4M | ||
Free Cash Flow | -$8.6M | ||
EBIT | -$6.4M | ||
EBITDA | -$6.4M | ||
Net Working Capital | $31.7M | ||
EPS | -$0.10 | ||
Enterprise Value/EBITDA | -7 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -6 | ||
PEG | -0 | ||
Price/Free Cash Flow | -6 | ||
Price/Operating Cash Flow | -6 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue